A longitudinal HR-pQCT (high-resolution peripheral quantitative computed tomography) study of alendronate treatment in postmenopausal women with low bone density: Relations among density, cortical and trabecular microarchitecture, biomechanics, and bone turnover.
Phase of Trial: Phase III
Latest Information Update: 14 Mar 2011
At a glance
- Drugs Alendronic acid (Primary)
- Indications Postmenopausal osteoporosis
- Focus Therapeutic Use
- 14 Mar 2011 New trial record